Akira Yoshida
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
YM155 exerts potent cytotoxic activity against quiescent (G0/G1) multiple myeloma and bortezomib resistant cells via inhibition of survivin and Mcl-1.
Journal: Oncotarget
Published: January 17, 2017
Combination of panobinostat with ponatinib synergistically overcomes imatinib-resistant CML cells.
Journal: Cancer science
Published: February 17, 2016
Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study.
Journal: Anticancer research
Published: December 16, 2014
The response to induction therapy is crucial for the treatment outcomes of elderly patients with acute myeloid leukemia: single-institution experience.
Journal: Anticancer research
Published: October 03, 2014
Reduced administration of rasburicase for tumor lysis syndrome: A single-institution experience.
Journal: Oncology letters
Published: May 08, 2014
Prognostic effect of peripheral blood cell counts in advanced diffuse large B-cell lymphoma treated with R-CHOP-like chemotherapy: A single institution analysis.
Journal: Oncology letters
Published: March 05, 2014
Gö6976, a FLT3 kinase inhibitor, exerts potent cytotoxic activity against acute leukemia via inhibition of survivin and MCL-1.
Journal: Biochemical pharmacology
Published: February 12, 2014
Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome.
Journal: Oncology letters
Published: November 11, 2013
A high serum uric acid level is associated with poor prognosis in patients with acute myeloid leukemia.
Journal: Anticancer research
Published: September 12, 2013
Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.
Journal: Anticancer research
Published: July 31, 2013
YM155 induces caspase-8 dependent apoptosis through downregulation of survivin and Mcl-1 in human leukemia cells.
Journal: Biochemical and biophysical research communications
Published: March 28, 2013
Last Updated: 09/26/2026